EU RESEARCHERS DEVELOP BLOOD SUPPLY MEDICINE
January 1st, 2007
BY KEITH NUTHALLA EUROPEAN Union (EU) research project called VASOPLUS is developing a new drug that can promote the formation of blood vessels in damaged hearts, without the usual side effects generated by such medicines. The initiative, which includes scientists from Belgium, Germany, Italy and South Africa, has been focusing on a signaling protein called 'placental growth factor' (PlGF), which controls blood formation within essential organs. A European Commission note stressed heart attack patients now use vasoprotector drugs to care for weakened hearts, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.